20/20 Biolabs, Inc. ($AIDX) Insider Transactions

Last updated: 2026-04-15 23:07 UTC | Total transactions: 13

In the last 12 months, insiders at 20/20 Biolabs, Inc. ($AIDX) filed 13 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.

20/20 Biolabs, Inc. operates in the Services-testing laboratories industry (Industrial Applications and Services sector).

Most Active Insiders

View all SEC Filings for 20/20 Biolabs, Inc. (AIDX).

Set Up your own filters →

Recent Insider Transactions

Transaction Date Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
April 2, 2026 Bergman Alan B. Chief Financial Officer A Stock Option 100000 $0.00 100,000.0000 4,930,287 9999.99% 2.03%
April 2, 2026 Zhou Jiming Chief Operating Officer A Stock Option 150000 $0.00 150,000.0000 4,930,287 9999.99% 3.04%
March 3, 2026 Cohen Jonathan M Chief Executive Officer A Stock Option 352936 $0.00 352,936.0000 0 9999.99% 0.00%
Feb. 19, 2026 Rollins John Woodson Director C Series A-2 Preferred Stock 6135 $0.00 0.0000 0 100.00% 0.00%
Feb. 19, 2026 Ross Michael A. Director C Common Stock 31 $0.00 31.0000 0 9999.99% 0.00%
Feb. 19, 2026 Ross Michael A. Director C Series A-2 Preferred Stock 31 $0.00 0.0000 0 100.00% 0.00%
Feb. 19, 2026 Rollins John Woodson Director C Common Stock 13029 $0.00 24,140.0000 0 117.26% 0.00%
Feb. 19, 2026 Compton John G. Director C Series A-2 Preferred Stock 7669 $0.00 0.0000 0 100.00% 0.00%
Feb. 19, 2026 COHEN RICHARD M Director C Common Stock 7700 $0.00 7,700.0000 0 9999.99% 0.00%
Feb. 19, 2026 COHEN RICHARD M Director C Series A-2 Preferred Stock 7700 $0.00 0.0000 0 100.00% 0.00%
Feb. 19, 2026 Compton John G. Director C Common Stock 7669 $0.00 14,335.0000 0 115.05% 0.00%
Feb. 19, 2026 Rollins John Woodson Director C Common Stock 6135 $0.00 30,275.0000 0 25.41% 0.00%
Feb. 19, 2026 Rollins John Woodson Director C Series A Preferred Stock 13029 $0.00 0.0000 0 100.00% 0.00%